하나제약

293480KOSPI

55.3 / 100

Reference Date: 2026-09-08

Financial Score22.5 / 40

News Sentiment18.8 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly down 4.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hana Pharmaceutical specializes in the production and sale of specialty pharmaceuticals, with a strong presence in analgesics and anesthetics. The company offers a wide range of health insurance-listed drugs and operates manufacturing plants in Hwaseong, Gyeonggi, along with an R&D center in Pangyo.

Number of Employees

706people

Average Salary

53.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

16.77Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.48Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

2.82Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

12.95Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲3.3% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.2% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 6.1% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75

Positive
R&D 하면 50%, 아니면 45%…'약가 당근' 통할까
정부의 제네릭 약가 인하 정책과 중소·중견 제약사를 위한 R&D 지원 제도 도입이 하나제약의 혁신적 성장 가능성을 높여 긍정적 영향을 미칠 것으로 예상된다.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 8,500Won52-week high 12,29052-week low 8,250

1-month return2.0Point

1m -4.28% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-27
Neutral반기보고서 (2026.06)2026-08-14